| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/24/2009 | CN101461816A Novel use of corilagin |
| 06/24/2009 | CN101461815A Triflusal medicament composition and preparation method thereof |
| 06/24/2009 | CN101461814A Medicament composition containing losartan and hydrochlorothiazidum |
| 06/24/2009 | CN101461813A Cefotiam hydrochloride preparation for injection and preparation method thereof |
| 06/24/2009 | CN101461812A Desloratadine pseudoephedrine capsule |
| 06/24/2009 | CN101461811A Loratadine orally disintegrating tablet and technique for preparing the same |
| 06/24/2009 | CN101461810A Oral solid medicament composition containing lafutidine |
| 06/24/2009 | CN101461809A Pantoprazole sodium enteric tablet and preparation method thereof |
| 06/24/2009 | CN101461808A Fluorofenidone solid dispersoid and preparation thereof |
| 06/24/2009 | CN101461807A Application of penehyclidine hydrochloride in preparing medicament for treating haemorrhagic shock |
| 06/24/2009 | CN101461806A Palonosetron injection and preparation method thereof |
| 06/24/2009 | CN101461805A Use of anti-hantavirus medicament arbidol |
| 06/24/2009 | CN101461804A (+)-1-(3,4-dichlorrophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereof |
| 06/24/2009 | CN101461803A Use of grape inner ester |
| 06/24/2009 | CN101461802A Application of epi-gallocatechin-3-gallate in preparing medicament for preventing and treating high-fat fatty liver |
| 06/24/2009 | CN101461801A Oxaliplatin medicament composition and preparation method thereof |
| 06/24/2009 | CN101461800A Application of compound butyl-isobutyl-dimethyl phthalate |
| 06/24/2009 | CN101461799A Stable pravastatin medicament composition and preparation method thereof |
| 06/24/2009 | CN101461798A Medicinal composition for oral use containing diisopropylamine dichloroacetate |
| 06/24/2009 | CN101461797A Use of highland barley bran linoleate |
| 06/24/2009 | CN101461796A Method for preparing metoclopramide hydrochloride sustained-release capsule |
| 06/24/2009 | CN101461795A Chloramphenicol ophthalmic preparation and method for preparing the same |
| 06/24/2009 | CN101461794A Use of frangula emodin in immuno suppressive medicament for resisting transplant rejection |
| 06/24/2009 | CN101461793A Method for preparing beta-elemene lipidosome and freeze-dried powder |
| 06/24/2009 | CN100503611C New use of specific cyclolignans |
| 06/24/2009 | CN100503608C Deazapurines and uses thereof |
| 06/24/2009 | CN100503605C Benzimidazole derivative and its use as AII receptor antagonist |
| 06/24/2009 | CN100503602C Benzopyran derivatives substituted with secondary amines including tetrazole, method for the preparation thereof and pharmaceutical compositions containing them |
| 06/24/2009 | CN100503600C Pesticidal heterocycles |
| 06/24/2009 | CN100503599C Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 06/24/2009 | CN100503598C Improved chemical process and pharmaceutical formulation |
| 06/24/2009 | CN100503596C Process for purifying 6-methoxy omeprazole |
| 06/24/2009 | CN100503592C Anti-AIDS virus active substance desmosdumotin D and desmosdumotin and its analogue |
| 06/24/2009 | CN100503589C Sulphona mide derivatives as prodrugs of aspartyl protease inhibitors |
| 06/24/2009 | CN100503580C Irreversible inhibitor of tyrosine kinase |
| 06/24/2009 | CN100503574C Substituted ideno[1,2-c]isoquinoline derivatives and methods of use thereof |
| 06/24/2009 | CN100503572C Caspase inhibitors and uses thereof |
| 06/24/2009 | CN100503570C Cyanoguanidine prodrugs |
| 06/24/2009 | CN100503566C Inhibitors of cytosolic phospholipase A2 |
| 06/24/2009 | CN100503562C Pyrrolidone derivatives as MAOB inhibitors |
| 06/24/2009 | CN100503560C Substituted cyclohexane derivatives |
| 06/24/2009 | CN100502911C An anti-rheumatism medicament and preparation method thereof |
| 06/24/2009 | CN100502893C Strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it |
| 06/24/2009 | CN100502889C Oral and dental composition |
| 06/24/2009 | CN100502888C Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative, potentially pathogenic gram-positive bacteria |
| 06/24/2009 | CN100502887C Buccal tablet of Asraguluspolysacharin |
| 06/24/2009 | CN100502886C Medicinal composition for treating dysmenorrhea and preparation process thereof |
| 06/24/2009 | CN100502885C Medicinal composition for treating dysmenorrhea and preparation process thereof |
| 06/24/2009 | CN100502884C Re-epithelializing pharmaceutical compositions comprising xanthan gum |
| 06/24/2009 | CN100502883C Cornel extract oral medicine compositions of low irritation to gastrointestinal tract and its preparation |
| 06/24/2009 | CN100502882C Application of aescin and its derivative in preparing medicine for treating acute pulmonary inflammation |
| 06/24/2009 | CN100502881C Degradable polymer supported nanometer daunorubicin microsphere and its preparation process |
| 06/24/2009 | CN100502880C Notoginseng glycol-saponin composition and its preparation method and use |
| 06/24/2009 | CN100502879C Application of a compound in preparing anti-virus medicament |
| 06/24/2009 | CN100502878C Fusidate sodium composition and preparation of its freeze-drying formulation |
| 06/24/2009 | CN100502877C Sustained-release prostaglandin I derivative preparation |
| 06/24/2009 | CN100502876C Thiophenepyrimidinones as 17-beta-hydroxysteroid dehydrogenase inhibitors |
| 06/24/2009 | CN100502875C Use of amitriptyline and / or berkomine in preparation of medicament for prophylaxis and treatment of infectious diseases |
| 06/24/2009 | CN100502874C Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure |
| 06/24/2009 | CN100502873C Formulations containing cephalosporin |
| 06/24/2009 | CN100502872C Effervescence tablet of sulfogaiacol pentoxyverine and its preparation technique |
| 06/24/2009 | CN100502871C Use of barbituric acid derivatives in preparation for medicament of treating movement disorders |
| 06/24/2009 | CN100502870C Medicinal composition containing rosuvastatin or pitavastatin and B vitamin series |
| 06/24/2009 | CN100502869C Application of a compound in preparing anti-virus medicament |
| 06/24/2009 | CN100502868C 3CL protease inhibitor of non-peptide SARS coronavirus and use thereof |
| 06/24/2009 | CN100502867C Preparation of sinomenine as antineoplastic medicament |
| 06/24/2009 | CN100502866C Combination therapy |
| 06/24/2009 | CN100502865C Application of a compound in preparing anti-AIDS medicament |
| 06/24/2009 | CN100502864C Medicinal composition for treating dysmenorrhea and preparation process thereof |
| 06/24/2009 | CN100502863C 2,4,5-trisubstituded thiazolyl derivatives and their anti-inflammatory activity |
| 06/24/2009 | CN100502862C Method and composition for reducing toxicity related to leflunomide treatment |
| 06/24/2009 | CN100502861C Medicament inhibiting sodium/calcium exchange system |
| 06/24/2009 | CN100502860C Method of regulating nicotine metabolism |
| 06/24/2009 | CN100502859C Use of columbin, isocolumbin, deoxidized fibraurin in preparing antiphlogistic medicine |
| 06/24/2009 | CN100502858C Use of naringenin and derivative in preparation of product for resisting cardiovascular and cerebrovascular disease |
| 06/24/2009 | CN100502857C Oral pharmaceutical composition for treating cardiovascular and cerebrovascular diseases and preparation method |
| 06/24/2009 | CN100502856C Treatment of dyskinesia |
| 06/24/2009 | CN100502855C Application of a compound in preparing anti-AIDS medicament |
| 06/24/2009 | CN100502854C Application of chlorogenic acid for preparing medicine to treat diabetes complications |
| 06/24/2009 | CN100502853C Remedy for virus disease |
| 06/24/2009 | CN100502852C Flurbiprofenbab preparation and its preparation method |
| 06/24/2009 | CN100502851C Formula and preparation method for compound ointment containing zinc undecylenate |
| 06/24/2009 | CN100502850C Medicinal composition of total capsicine compounds and beta-cyclodextrin or derivative of beta-cyclodextrin |
| 06/24/2009 | CN100502849C Use of Chinese small iris seed extract A and its derivative and analogs in preparation of anti-cancer medicine |
| 06/24/2009 | CN100502848C Use of Chinese small iris seed extract A and its derivative and analog in preparation of chemical therapeutical sensitizing agent |
| 06/24/2009 | CN100502847C Compositions containing substituted quinolines and substituted diphenyl sulfones and its pharmaceutical use |
| 06/24/2009 | CN100502846C 3,4,5,-substituted benzyl ethylene derivatives and their preparation and use |
| 06/24/2009 | CN100502845C Compounds for treating and preventing exercise-induced cardiac arrhythmias and its preparation method |
| 06/24/2009 | CN100502839C Pre-formulation for the tabletting of natural mixtures of conjugated estrogens |
| 06/24/2009 | CN100502834C Amphotericin B structured emulsion |
| 06/24/2009 | CN100502724C Folding table and bench system |
| 06/24/2009 | CN100502675C Oil containing unsaturated fatty acid |
| 06/23/2009 | USRE40794 Antibiotic product for therapy of infections; purification for improved purity and stability |
| 06/23/2009 | USRE40793 treating conditions related to impairment of gastric emptying, gastromotility disorders; superior gastrokinetic properties; e.g. trans-4-amino-N-[(1-butyl-3-hydroxy-4-piperidinyl)methyl]-5-chloro-2,3-dihydro-7-benzofurancarboxamide |
| 06/23/2009 | USRE40792 treating CANCER, PMS, MENOPAUSE AND HYPERCHOLESTEROLEMIA with plant extract of soya or clover and isoflavones from Genistein, Daidzein, Biochanin A, Formononetin or the natural glycosides; dosage forms |
| 06/23/2009 | US7550628 Process for preparing phenolic acid salts of gabapentin |
| 06/23/2009 | US7550625 Esters of florfenicol |
| 06/23/2009 | US7550624 For treating or inhibiting increased urinary urgency or urinary incontinence and/or pain |
| 06/23/2009 | US7550609 Biological conjugates for tumor targeted treatment; novel taxanes having mercapto or disulfide groups; side effect reduction without compromising their cytotoxicity |
| 06/23/2009 | US7550603 1H-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent PARP inhibitors |